Soriano V - Search Results

1

HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.

Pieniazek D, Rayfield M, Hu DJ, Nkengasong JN, Soriano V, Heneine W, Zeh C, Agwale SM, Wambebe C, Odama L, Wiktor SZ. Pieniazek D, et al. Among authors: soriano v. AIDS. 2004 Feb 20;18(3):495-502. doi: 10.1097/00002030-200402200-00016. AIDS. 2004. PMID: 15090802

2

Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance.

de Mendoza C, Garrido C, Corral A, Zahonero N, Soriano V. de Mendoza C, et al. Among authors: soriano v. AIDS. 2008 Jan 11;22(2):311-3. doi: 10.1097/QAD.0b013e3282f4244f. AIDS. 2008. PMID: 18097236

3

Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance.

de Mendoza C, Valer L, Bacheler L, Pattery T, Corral A, Soriano V. de Mendoza C, et al. Among authors: soriano v. AIDS. 2006 Apr 24;20(7):1071-4. doi: 10.1097/01.aids.0000222084.44411.cc. AIDS. 2006. PMID: 16603864

4

High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid.

Holguín A, Alvarez A, Soriano V. Holguín A, et al. Among authors: soriano v. AIDS. 2002 May 24;16(8):1163-70. doi: 10.1097/00002030-200205240-00010. AIDS. 2002. PMID: 12004275

5

High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART.

Rodés B, Toro C, Sheldon JA, Jiménez V, Mansinho K, Soriano V. Rodés B, et al. Among authors: soriano v. AIDS. 2006 Jan 2;20(1):127-9. doi: 10.1097/01.aids.0000196171.35056.6c. AIDS. 2006. PMID: 16327332

6

Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors.

Poveda E, Blanco F, García-Gascó P, Alcolea A, Briz V, Soriano V. Poveda E, et al. Among authors: soriano v. AIDS. 2006 Jul 13;20(11):1558-60. doi: 10.1097/01.aids.0000237375.23692.f4. AIDS. 2006. PMID: 16847414

7

Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes.

Poveda E, de Mendoza C, Parkin N, Choe S, García-Gasco P, Corral A, Soriano V. Poveda E, et al. Among authors: soriano v. AIDS. 2008 Mar 12;22(5):611-6. doi: 10.1097/QAD.0b013e3282f51eb9. AIDS. 2008. PMID: 18317002

8

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues.

Poveda E, de Mendoza C, Pattery T, González Mdel M, Villacian J, Soriano V. Poveda E, et al. Among authors: soriano v. AIDS. 2008 Nov 12;22(17):2395-8. doi: 10.1097/QAD.0b013e32831692fb. AIDS. 2008. PMID: 18981781

9

High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor.

Seclén E, González Mdel M, Corral A, de Mendoza C, Soriano V, Poveda E. Seclén E, et al. Among authors: soriano v. AIDS. 2010 Jan 28;24(3):467-9. doi: 10.1097/QAD.0b013e328335ce07. AIDS. 2010. PMID: 19996935

10

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.

de Mendoza C, del Romero J, Rodríguez C, Corral A, Soriano V. de Mendoza C, et al. Among authors: soriano v. AIDS. 2002 Sep 6;16(13):1830-2. doi: 10.1097/00002030-200209060-00019. AIDS. 2002. PMID: 12218398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,490 results

Search Page

Filters